* Click a shape in the chart for more information
Ebola Virus Disease (EVD), is a severe, often fatal human illness. It is most common in central and west Africa. EVD is transmitted to people from wild animals and spreads in humans through human-to-human transmission (fluid transfer). EVD's average fatality rate is around 50%, though early supportive care with re-hydration and symptomatic treatment improves the patient's survival chance. There is currently no licensed treatment proven to neutralize (kill) the virus, but there are a number of treatments under development.
Do not test
Exposure within 3 weeks before symptoms?
Do any of the following conditions apply?
- Contact with blood or other body fluids of patient known to have or suspected to have EVD
- Residence in or traveled to an area where EVD transmission is active (Guinea, Sierra Leone, Liberia, or Nigeria)
- Diredct handling of bats, rodents, or primates or raw bushmeat from EVD areas?
- Precutaneous or Mucous membrane exposure or direct skin contact with body fluids of a person with confirmed or suspected EVP
- Laboratory processing of bodily fluids of suspected or confirmed EVD
- Participation in funeral rites or other direct exposure to human remains in EVD areas
- Provided patient care or casual contact with confirmed or suspected patients of EVD
- Houshold member or other casual contact of an EVD patient
- Person who had direct unprotected contact with bats or primates from EVD areas
No Known Exposure:
- Person who has residence in, or has traveld to Guinea, Sierra Leone, Liberia, or Nigeria
If your patient has ANY of the below symptoms, they are suspected.
- Fever of 101.5 F (38.6 C) or higher
- Severe headache, muscle pain, vomiting, diarrhea, abdominal pain, hiccups, or unexplained hemorrage
- Unknown or abnormal blood work including:
- lymphocytopenia <1,000 cells/uL
- Thrombocytopenia <150,000 cells/uL
- Elevated hepatic transaminases
Immediately implement infection control measures, report to your county health department or Bureau of Epidemiology (850) 245-4401 to authorize testing
Report to DOH to discuss the possible need for conditional release and movement restrictions.